Answers are grounded in this paper and cite their sources.
Introduction: This is an immunohistochemical (IHC) pilot study of adult patients who underwent allogeneic stem cell transplantation (alloSCT) for hematological disease and had BKPyV reactivation (BKPyV viruria) as well as graft-versus-host-disease (GvHD) to investigate, if there is an association between these two diseases. Methods: The study was prospectively registered at the German Clinical Trials Register (https://drks.de/search/en/trial/DRKS00039127/details). The full protocol is available with this link. Results: Seven (58.3%) of the identified patients were treated in our prospective clinical trial regarding urological complications in alloSCT. All of them had BKPyV viruria during inpatient treatment for the transplantation and developed acute GvHD of the skin. Five (41.7%) of the patients were recruited in our prospective study of long-term survivors (more than five years) of alloSCT. All of them had BKPyV viruria as well as chronic GvHD of the skin at time of their examination. Acute myeloid leukemia was the most frequent underlying indication for alloSCT (n=7; 58.3%), followed by Non-Hodgkin-Lymphoma (NHL; n=2; 16,7%). Interestingly, IHC was negative for LTAg as well as VP1 in all patients. Therefore, it must also be stated that both virus proteins were negative in IHC for acute as well as chronic GvHD of the skin. Consequently, no further molecular investigations were realized. Conclusion: There is no evidence for an association between the viral proteins LTAg and VP1 of BKPyV and skin GvHD in immunohistochemistry. Due to the pilot character of our investigation, the results should be interpreted with great caution.
No takes yet. Share an insight, caveat, or question.
Asadikomeleh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: